Gabather AB Company Description

Gabather AB (publ), a pharmaceutical company, develops drug candidates for the treatment of central nervous system diseases.

The company offers drugs primarily in the areas of anti-psychotics, anti-depressants and anxiolytics, and analgesics, as well as cognition-enhancing treatments, including Alzheimer’s disease.

It focuses on developing GT-002, a pro-cognitive drug candidate for the treatment of Alzheimer’s disease, schizophrenia, and major depressive disorders.

The company was incorporated in 2014 and is based in Södertälje, Sweden.

Gabather AB (publ)

Country	Sweden
Founded	2014
Industry	Pharmaceutical Preparations
Employees	3
CEO	Michael-Robin Witt

Contact Details

Address: Forskargatan 20J Södertälje, 151 36 Sweden
Phone	46 7 36 87 28 39
Website	gabather.com

Stock Details

Ticker Symbol	5J2
Exchange	Frankfurt Stock Exchange
Fiscal Year	January - December
Reporting Currency	SEK
SIC Code	2834

Key Executives

Name	Position
Michael-Robin Witt	Chief Executive Officer
Christine Ryan	Chief Operating Officer